Austin—[Updated 2:13 p.m. See below.] Intel Capital is leading a $7 million Series A round of funding for Austin, TX-based GenXComm, a startup developing wireless technology that reduces interference in transmitters of 5G mobile, Wi-Fi, and cable networks... Read more »
The annual American Society of Hematology meeting is nearly over. For now, we’ve chosen updates from three disease areas to highlight, plus the more notable market movements. No surprise, there’s a lot about the genetically engineered cell therapy known as CAR-T.... Read more »
Whether you think self-driving cars are the stuff of science fiction or a potentially paradigm-shifting new form of transportation, autonomous vehicles are coming—and the companies developing them are spending big money to make it happen.
A few years ago, industry analysts... Read more »
With 2018 around the corner, this was a week to look ahead. At Xconomy, we zeroed in on several clinical trials that could become major stories in the life sciences. Other healthcare milestones are on the way, too.
The FDA will... Read more »
San Antonio — StemBioSys, a life sciences company with a system for growing stem cells, has made a deal to have its products distributed in the United Kingdom and Western Europe.
The deal is with Caltag Medsystems, a life science... Read more »
How do you disrupt an industry that markets itself as the embodiment of “forever?”
You bring it back to basics, says Lindsay Reinsmith, co-founder of Ada Diamonds, an online retailer of jewelry with lab-made gemstones in San Francisco. “Science is on... Read more »
[Corrected, 12/11/17, 1 p.m. ET. See below.] On Monday we posted the first part of our look at what should be some of 2018’s most important clinical data, including trials for lung cancer, heart disease, melanoma, Alzheimer’s disease,... Read more »
Austin—Seven years ago, Scott Hanson was a student at University of Michigan who was hoping to raise a few hundred thousand dollars for Ambiq Micro, his fledgling startup that aimed to make low-powered microcontrollers.
Today, Ambiq is headquartered in... Read more »
Genetically modified medicine is here. Two CAR-T therapies, made from a patient’s living T cells, are on the market in the U.S., and many more are in various stages of clinical testing.
As remarkable as they might seem, however, these medicines... Read more »
Author, investor, and AOL co-founder Steve Case today announced a new $150 million venture fund aimed at pumping investment capital into tech companies in so-called flyover states. Contributing to the fund is an impressive group of some of the most successful... Read more »
San Antonio—Data backup company Jungle Disk has acquired an online data backup service for users of QuickBooks Online—a move toward offering backup support for more software-as-a-service (Saas) products.
Jungle Disk already sells small businesses an encrypted file backup service for... Read more »
Many of biotech’s biggest stories in 2017 followed the highly anticipated data from clinical studies. There were monumental successes, like the first-ever approval of a genetically modified living cell therapy, the first FDA application for a gene therapy or a... Read more »
San Antonio—Stumping for a political candidate can be a mixed bag. For every friendly conversation, you’ll get at least one that’s filled with complaints—about the government, about potholes, about neighbors, about anything.
That’s something Alberto Altamirano discovered when he was... Read more »